<DOC>
	<DOCNO>NCT02765074</DOCNO>
	<brief_summary>Rheumatoid arthritis ( RA ) chronic inflammatory disease mediate production several cytokine , lead destruction bone cartilage tissue multiple joint bone loss . Conventional radiograph ( CR ) consider gold standard diagnosis follow joint change RA . But method low sensitivity detect early erosive change unable evaluate periarticular bone loss . High Resolution peripheral QCT ( HRpQCT ) enable detection erosion less 0.5 mm width depth metacarpo-phalangeal ( MCP ) joint . Using 3-D high resolution analysis cortical bone erosion , one also able evaluate volume erosion evolution treatment IL6 ( 6- interleukin ) play major role inflammatory process bone damage relate RA . Tocilizumab ( TCZ ) humanize anti-IL-6R monoclonal antibody , develop investigated several clinical trial RA . This biotherapy , association methotrexate ( MTX ) give monotherapy , efficient RA inadequate response MTX anti-TNF b ( tumor necrosis factor ) . TCZ reduce dramatically systemic inflammation , structural progression improve clinical symptom quality life . Tocilizumab may help reduce bone erosion , periarticular osteopenia systemic bone loss .</brief_summary>
	<brief_title>Filling Bone Erosions : Longitudinal Multicentric HR-pQCT Study Subcutaneous Tocilizumab Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Active RA , &lt; 10 year disease duration , diagnose accord ACREULAR 2010 classification criterion DAS 28 superior equal 3.2 despite DMARD biological treatment ( tocilizumab ) Superior equal one joint erosion right leave MCP 2 , 3 Xrays Oral corticosteroid ≤ 10 mg/day prednisone equivalent stable least one month RA patient eligible subcutaneous Tocilizumab monotherapy Treatment zoledronic acid denosumab ( less one year ) Intraarticular injection corticosteroid MCP previous three month Tocilizumab contraindication accordance SPC ( Summary Product Characteristics ) : Hypersensitivity active substance excipients Active , severe infection include active tuberculosis Diverticulitis Active hepatic disease hepatic Impairment include viral hepatitis Elevated Alanine Aminotransferase Aspartate Aminotransferase &gt; 5×ULN Absolute neutrophil count &lt; 0.5 × 10 exp 9 /L Platelet count &lt; 50×10 exp 3 /μL , General : Absence inform consent Prior plan joint surgery hand might impact interpretation image assessment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>subcutaneous tocilizumab</keyword>
	<keyword>High Resolution peripheral QCT ( HR-pQCT )</keyword>
	<keyword>bone erosion</keyword>
	<keyword>bone microarchitecture</keyword>
	<keyword>rheumatoid arthritis</keyword>
</DOC>